ArticleJournal of neuro-oncology2026
Significance of shunt placement for secondary communicating hydrocephalus in patients with high-grade glioma.
Article in Journal of neuro-oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeHydrocephalus is a common complication of high-grade glioma (HGG). However, the indications for and prognostic impact of shunt placement remain unclear. We aimed to assess the shunt placement effectiveness and safety for hydrocephalus in patients with HGG and identify clinical factors associated with neurological and survival outcomes.
methodsWe retrospectively identified HGG patients with communicating hydrocephalus (CH) treated at our hospital between October 2010 and December 2024. Patient characteristics, changes in Karnofsky Performance Status (KPS) before and after shunt placement, and survival were analyzed in these patients.
resultsDuring the study period, 31 HGG patients underwent shunt placement for CH. For the patients, positive lumbar tap test results and a shorter duration from KPS decline to shunt placement were significantly associated with greater KPS improvement in analyses (p = 0.034 and 0.043). No patients showed KPS improvement when shunt placement was performed more than three months after KPS decline. For the patients who experienced an improved KPS score after shunt surgery, the median postshunting survival was 20.0 months. Postsurgical infection was observed in two cases (6.4%), and shunt revision surgery was required in three cases (9.6%).
conclusionsShunt placement may be considered in selected patients with HGG and CH, particularly those with a positive lumbar tap test and a short interval from KPS decline.
Indexed as
Identifiers
41934540What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.